N-α-Fmoc-L-tryptophan is a protected amino acid derivative of L-tryptophan in which the α-amino group is carbamylated with the Fmoc (9H-fluoren-9-ylmethoxycarbonyl) protecting group, retaining the indole-containing tryptophan side chain. The molecule contains a free carboxylic acid functionality and an Fmoc-protected α-amino group, with the aromatic indole side chain providing a conjugated, hydrogen-bonding capable moiety that can participate in noncovalent interactions during peptide assembly. As an Fmoc-protected amino acid, it is used as a building block for stepwise peptide synthesis, including solid-phase peptide synthesis workflows, where the Fmoc group controls chemoselectivity by preventing unprotected amine reactivity until deprotection.
CAT No: CP02015
CAS No:35737-15-6
Synonyms/Alias:Fmoc-Trp-OH;35737-15-6;Nalpha-FMOC-L-Tryptophan;Fmoc-L-tryptophan;Fmoc-L-Trp-OH;N-Fmoc-L-Tryptophan;CHEMBL292051;MGHMWKZOLAAOTD-DEOSSOPVSA-N;ST080687;Nalpha-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-tryptophan;(S)-2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-3-(1H-INDOL-3-YL)PROPANOICACID;(S)-2-(9H-Fluoren-9-ylmethoxycarbonylamino)-3-(1H-indol-3-yl)-propionicacid;C26H22N2O4;N(alpha)-Fmoc-L-tryptophan;Fmoc-Trp;(2S)-2-([(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO)-3-(1H-INDOL-3-YL)PROPANOICACID;(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-3-(1H-indol-3-yl)propanoicacid;9-FLUORENYLMETHOXYCARBONYL-L-TRYPTOPHAN;AC1LJQOF;PubChem10045;FMOC-L-TRP;N-|A-Fmoc-L-tryptophan;N-[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]-L-TRYPTOPHAN;KSC223A7J;MLS001359854
N-α-Fmoc-L-tryptophan is an Fmoc-protected L-tryptophan amino acid in which the α-amino group is masked by the fluorenylmethoxycarbonyl (Fmoc) protecting group, while the carboxylic acid remains available for coupling or further protection. The indole side chain retains its characteristic aromatic and heteroaromatic reactivity, enabling selective functionalization and participation in noncovalent interactions during peptide assembly and molecular recognition studies. The stereogenic α-center is fixed as the L configuration, supporting stereochemically defined peptide bond formation under standard amino acid coupling conditions. The combination of an orthogonally removable N-protecting group and a reactive indole ring makes this compound a practical chiral building block and protected amino acid intermediate for peptide synthesis and downstream derivatization.
1. Peptide Synthesis
N-α-Fmoc-L-tryptophan is used in peptide building workflows where Fmoc chemistry supports iterative N-terminal deprotection and coupling. The protected α-amino group, paired with the free carboxylic acid functionality, enables formation of amide bonds while maintaining the L-configuration at the residue level. The indole side chain can remain intact during chain assembly or be selectively modified later, depending on the protection strategy chosen for indole reactivity. The resulting Trp-containing peptide fragments and full-length sequences can be accessed for structure-function studies, peptide library generation, and synthetic methodology development in peptide science.
2. Chemical Biology
N-α-Fmoc-L-tryptophan is applied in chemical biology research to introduce tryptophan residues into peptides and peptidomimetic probes that engage in aromatic stacking, hydrogen bonding, and hydrophobic recognition. The indole ring provides a chemically addressable motif for conjugation-compatible transformations, including controlled oxidation, electrophilic substitution, or derivatization to create binding or spectroscopic handles. The Fmoc-protected amino acid format supports incorporation into defined sequences using standard protected amino acid coupling logic, enabling reproducible probe construction. Downstream derivatives can serve as molecular recognition elements, affinity reagents, or scaffold components for studying biomolecular interactions at the residue level.
3. Side-Chain Functionalization
N-α-Fmoc-L-tryptophan is suitable for side-chain functionalization routes where the indole moiety is leveraged as a reactive aromatic heterocycle. The compound's stable Fmoc-protected α-amino group allows orthogonal handling: indole-targeted modifications can be planned either before or after peptide coupling, while the α-amino protection suppresses undesired amide formation during intermediate transformations. The carboxylic acid can be converted into activated derivatives or protected as needed to control chemoselectivity in multi-step synthesis. Functionalized tryptophan analogs derived from this intermediate can feed into peptidomimetic design, receptor-binding studies, and synthetic organic chemistry programs requiring chiral, residue-defined intermediates.
4. Drug Discovery
N-α-Fmoc-L-tryptophan is employed in drug discovery chemistry for constructing peptide-like scaffolds and constrained peptidomimetics that incorporate a stereodefined tryptophan residue. The Fmoc-protected amino acid format supports rapid assembly of sequence variants for structure-activity relationship studies, while the indole side chain contributes a persistent aromatic pharmacophore for binding-site interactions. The α-carboxyl group supports controlled coupling to diverse fragments, enabling systematic exploration of N-terminal and C-terminal modifications when paired with appropriate protecting-group strategies. Synthesized Trp-containing analogs can then be advanced as biochemical research leads, assay reagents, or fragment-derived intermediates for medicinal chemistry optimization.
5. Pharmaceutical Manufacturing
N-α-Fmoc-L-tryptophan is relevant to pharmaceutical manufacturing workflows that require reproducible, residue-defined protected amino acid inputs for peptide intermediate preparation. The Fmoc group provides a manufacturing-compatible protection strategy that can be removed under base conditions during solid-phase or controlled solution-phase assembly, while the indole side chain remains chemically manageable with appropriate orthogonal protection choices. The fixed L stereochemistry at the α-center supports consistent peptide bond stereochemistry across batch production of Trp-containing intermediates. Downstream, the compound can be used to generate defined peptide segments that feed into larger active ingredient synthesis, analytical reference material preparation, and process development for peptide-based products.
1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
3. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.